Agency Information Collection Activities; Proposed Collection; Comment Request; Expanded Access to Investigational Drugs for Treatment Use
The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public commen...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- July 28, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public commen...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Drug Alerts and Statements
Botulism: clinical and public health management
Information for healthcare professionals on the diagnosis and treatment of infant botulism, foodborn...
Withdrawn and Expired Guidances | Drugs
Bioscience and health technology sector statistics 2024 to 2025
Official statistics in development estimating the size and composition of the life sciences sector i...